Cutaneous squamous cell carcinoma: the frontier of cancer immunoprevention

MS Chang, M Azin, S Demehri - Annual Review of Pathology …, 2022 - annualreviews.org
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with its
incidence rising steeply. Immunosuppression is a well-established risk factor for cSCC, and …

HIV-associated psoriasis: pathogenesis, clinical features, and management

N Morar, SA Willis-Owen, T Maurer… - The Lancet infectious …, 2010 - thelancet.com
Psoriasis is a chronic papulosquamous skin disease that is thought to be a T-cell-mediated
autoimmune disorder of keratinocyte proliferation. The association between psoriasis and …

Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global …

W Zhang, W Zeng, A Jiang, Z He, X Shen… - Cancer …, 2021 - Wiley Online Library
Background Information about global and local epidemiology and trends of skin cancers is
limited, which increases the difficulty of cutaneous cancer control. Methods To estimate the …

Non-melanoma skin cancer

V Madan, JT Lear, RM Szeimies - The lancet, 2010 - thelancet.com
The rising incidence and morbidity of non-melanoma skin cancers has generated great
interest in unravelling of their pathogenesis and in the search for new non-invasive …

Changing incidence trends of cutaneous T-cell lymphoma

K Korgavkar, M Xiong, M Weinstock - JAMA dermatology, 2013 - jamanetwork.com
Importance Cutaneous T-cell lymphoma (CTCL) incidence and survival have been
increasing steadily for over 25 years. Objective We sought to measure changes in CTCL …

Melanoma in immunosuppressed patients

AW Kubica, JD Brewer - Mayo Clinic Proceedings, 2012 - Elsevier
The immunogenic characteristics of malignant melanoma are intriguing. To date, multiple
studies exist regarding the immunogenicity of melanoma. In this article, we summarize data …

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

TC Ling, TH Clayton, J Crawley… - British Journal of …, 2016 - academic.oup.com
Guidelines Research and Evaluation (AGREE II) instrument (www. agreetrust. org). 2
Recommendations were developed for implementation in the National Health Service using …

Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL)

FM Ghazawi, N Alghazawi, M Le… - Frontiers in …, 2019 - frontiersin.org
The applications of disease cluster investigations in medicine have developed rather rapidly
in recent decades. Analyzing the epidemiology of non-random aggregation of patients with a …

Infectious agents in cutaneous T-cell lymphoma

ED Mirvish, RG Pomerantz, LJ Geskin - Journal of the American Academy …, 2011 - Elsevier
Infectious agents have long been suspected as potential causative agents in cutaneous T-
cell lymphoma (CTCL). Tissues of patients with CTCL have been evaluated for evidence of …

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies

V To, VJ Evtimov, G Jenkin, A Pupovac… - Frontiers in …, 2022 - frontiersin.org
Chimeric antigen receptor (CAR)-T therapy has demonstrated remarkable outcomes for B
cell malignancies, however, its application for T cell lymphoma, particularly cutaneous T cell …